Something happened to restrain the price jump, that is for sure.. I expected a double today and a rising upward for the next few weeks. The impact of this drug is tremendous and is going to gobble up market share from all other pain relief drug makers. This drug is a game changer for chronic pain sufferers and it is so big that I actually expect multiple buyout offers from the larger pharmaceutical companies in the next few weeks.. I'm speculating a buyout at $10/share but it could be a bit more or a bit less.